Related references
Note: Only part of the references are listed.Systematic Review and Meta-Analysis of the Significance of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates
Sebastiaan J. van Hal et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Comparison of Detection Methods for Heteroresistant Vancomycin-Intermediate Staphylococcus aureus, with the Population Analysis Profile Method as the Reference Method
Sarah W. Satola et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Detection and Characterization of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates in Canada: Results from the Canadian Nosocomial Infection Surveillance Program, 1995-2006
Heather J. Adam et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications
Benjamin P. Howden et al.
CLINICAL MICROBIOLOGY REVIEWS (2010)
Prevalence and Characterization of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates from 14 Cities in China
Wenjia Sun et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Prospective Comparison of the Clinical Impacts of Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus (MRSA) and Vancomycin-Susceptible MRSA
K. C. Horne et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
European Society of Clinical Microbiology and Infectious Diseases (ESCMID): Data review and recommendations for diagnosing Clostridium difficile-infection (CDI)
M. J. T. Crobach et al.
CLINICAL MICROBIOLOGY AND INFECTION (2009)
Evaluation of the Etest GRD for the detection of Staphylococcus aureus with reduced susceptibility to glycopeptides
Steven N. Leonard et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Vancomycin MIC plus Heteroresistance and Outcome of Methicillin-Resistant Staphylococcus aureus Bacteremia: Trends over 11 Years
Adina C. Musta et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin
T. P. Lodise et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Evaluation of a new etest vancomycin-teicoplanin strip for detection of glycopeptide-intermediate Staphylococcus aureus (GISA), in particular, heterogeneous GISA
Anne Yusof et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Characterization of vancomycin-heteroresistant Staphylococcus aureus from the metropolitan area of Detroit, Michigan, over a 22-year period (1986 to 2007)
Michael J. Rybak et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
A multicenter study evaluating the current strategies for isolating Staphylococcus aureus strains with reduced susceptibility to glycopeptides
Mandy Wootton et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections -: Efficacy and toxicity
Levita K. Hidayat et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacterernia
Benjamin P. Howden et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus
L Cui et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides
TR Walsh et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2001)
A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital
M Wootton et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Share Paper
